Answers are grounded in this paper and cite their sources.
, P = 0.9) in the optimal KDPI-matched cohort. Recipients who received HCV Ab positive, but NAT-negative donor kidneys did not experience worse 6-month eGFR than correctly matched HCV Ab-/NAT- recipients.
No takes yet. Share an insight, caveat, or question.
Yazawa et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: